Modulation of the Immune System by Mammary Tumor-Derived Factors

References

• Sigel M M, Lopez D M, Ortiz-Muniz G. In vitro immune responses to viral and tumor antigens in murine breast cancer. Cancer Res 1976; 36: 748–752
   PubMed Web of Science ®Google Scholar
• Efskind L, Godal T, Grade T, et al. Progressive atrophy of the thymus in mice carrying Lewis lung carcinoma grafts. Cancer Immunol Immunother 1978; 3: 207–209
   Web of Science ®Google Scholar
• Paul R D, Ghaffen A, Sigel M M, et al. Splenic alterations during mammary tumorigenesis diverse effects on different immune parameters. Anticancer Res 1981; 1: 63–69
   PubMed Web of Science ®Google Scholar
• Lopez D M, Sigel M M, Charyulu V. Kinetics of responses to tumor antigens and mouse mammary tumor virus in BALB/cCrgl mice. J Natl Cancer Inst 1981; 66: 191–196
   PubMed Web of Science ®Google Scholar
• Gerson J M, Varesio L, Herberman R B. Systemic and in situ natural killer and suppressor cell activities in mice bearing progressively growing murine sarcoma-virus-induced tumors. Int J Cancer 1981; 27: 243–248
   PubMed Web of Science ®Google Scholar
• Lopez D M, Paul R D. Analysis of the lymphoid cells responding to viral and tumor asociated antigens in spleens of syngeneic mouse mammary tumor systems with low and high oncogenic potentials. J Natl Cancer Inst 1981; 69: 1403–1409
   Web of Science ®Google Scholar
• Buessow S C, Paul R D, Lopez D M. Influence of mammary tumor progression on phenotype and function of spleen and in situ lymphocytes in mice. J Natl Cancer Inst 1984; 73: 249–255
   PubMed Web of Science ®Google Scholar
• Kovacs C J, Emma D A, Evans M J, et al. Hemopoietic modulation in tumor bearing animals of enhanced progenitor cell production in femoral marrow. Cell Tissue Kinet 1985; 18: 235–246
   PubMedGoogle Scholar
• Robin R A. T cell response at the host-tumor interface. Biochem Biophys Acta 1986; 865: 289–305
   PubMed Web of Science ®Google Scholar
• Miescher S, Whiteside T L, Carrel S, et al. Functional properties of tumor-infiltrating and blood lymphocytes in patients with solid tumors: effects of tumor cells and their supernatants on proliferation responses of lymphocytes. J Immunol 1986; 136: 1899–1903
   PubMed Web of Science ®Google Scholar
• Garner R E, Malick A P, Yurochko A D, et al. Shifts in macrophage (Mø) surface phenotypes during tumor growth: Association of Mac-2+ and Mac-3+ Mø with immunosuppressive activity. Cell Immunol 1987; 108: 255–268
   PubMed Web of Science ®Google Scholar
• Paul R D, Lopez D M. Induction of “innocent bystander” cytotoxicity in nonimmune mice by adoptive transfer of L3T4+ Lyt 1+2− mammary tumor immune T cells. Cancer Res 1987; 47: 1105–1110
   PubMed Web of Science ®Google Scholar
• Yanaka K, Koga Y, Taniguchi K, et al. T cell recruitment from the thymus to spleen in tumor bearing mice. Cancer Res 1987; 47: 2136–2141
   PubMed Web of Science ®Google Scholar
• Pollack S B, Lee M Y, Cohen E, et al. Modulation of murine natural killer cells by a granulocytosis-inducing tumor. Cancer Res 1989; 49: 174–178
   PubMed Web of Science ®Google Scholar
• Kirchner H, Chusea T M, Herberman R B, et al. Evidence of suppressor cell activity in spleens of mice bearing primary tumors induced by Moloney sarcoma virus. J Exp Med 1974; 139: 1473–1482
   PubMed Web of Science ®Google Scholar
• Blazar B A, Miller F R, Heppner G H. In situ cells of mouse mammary tumors m. In vitro stimulation of tumor cell survival by lymphoid cells separated from mammary tumors. J Immunol 1978; 120: 1887–1891
   PubMed Web of Science ®Google Scholar
• Kadhim S A, Rees R C. Enhancement of tumor growth in mice: evidence for the involvement of host macrophages. Cell Immunol 1984; 87: 259–269
   PubMed Web of Science ®Google Scholar
• Buessow S C, Paul R D, Miller A M, et al. Lymphoreticular cells isolated by centrifugal elutriation from a mammary adenocarcinoma. I. Characterization of an in situ lymphocyte suppressor population by surface markers and functional reactivity. Int J Cancer 1984; 33: 79–85
   PubMed Web of Science ®Google Scholar
• North R J. Development of the antitumor immune response. Adv Cancer Res 1985; 45: 1–43
   PubMed Web of Science ®Google Scholar
• Hoon D BS, Bowker R J, Cochran A T. Suppressor cell activity in melanoma draining lymph nodes. Cancer Res 1987; 47: 1740–1744
   PubMed Web of Science ®Google Scholar
• Nelson D S, Nelson M. Evasion of host defenses by tumor. Immunol Cell Biol 1987; 65: 287–304
   PubMed Web of Science ®Google Scholar
• Young M R, Newby M, Wepsic H T. Hemopoiesis and suppressor bone marrow cells in mice bearing large metastatic Lewis lung carcinoma. Cancer Res 1987; 47: 100–108
   PubMed Web of Science ®Google Scholar
• Young M R, Aquino S, Young M E. Differential induction of hematopoiesis and immune suppressor cells in the bone marrow versus in the spleen by Lewis lung carcinoma variants. J Leuk Biol 1989; 45: 262–273
   PubMed Web of Science ®Google Scholar
• Varesio L, Giovarelli M, Landolfo S, et al. Suppression of proliferative response and lymphokine production during the progression of a spontaneous tumor. Cancer Res 1979; 39: 4983–4988
   PubMed Web of Science ®Google Scholar
• Plescia O J, Smith A H, Grinwich K. Subversion of immune system by tumor cells and role of prostaglandins. Proc Natl Acad Sci (USA) 1975; 72: 1848–1851
   PubMed Web of Science ®Google Scholar
• Pelus L M, Bockman R S. Increased prostaglandin synthesis by macrophages from tumor bearing mice. J Immunol 1979; 123: 2118–2125
   PubMed Web of Science ®Google Scholar
• Goodwin J S, Husby G, Williams R C. Prostaglandin E and cancer growth. Cancer Immumnol Immunother 1980; 8: 3–7
   Web of Science ®Google Scholar
• Leung K H, Fischer D G, Koren H S. Erythromyeloid tumor cells (K562) induce PGE synthesis in human peripheral blood monocytes. J Immunol 1983; 131: 445–449
   PubMed Web of Science ®Google Scholar
• Young M R, Knies S. Prostaglandin E production by Lewis lung carcinoma: Mechanism for tumor establishment in vivo. J Natl Cancer Inst 1984; 72: 919–922
   PubMed Web of Science ®Google Scholar
• Bonaventure J, Nigram V N, Brailovsky C A. Modulation of the immunosuppressive effects of splenic macrophages in Fischer rats bearing adenocarcinoma 13762. Cancer Immunol Immunother 1985; 20: 167–173
   PubMed Web of Science ®Google Scholar
• Allison A C. Mechanism by which activated macrophages inhibit lymphocyte responses. Immuno Rev 1985; 40: 3–35
   Google Scholar
• Malick A P, Elgert K D, Garner R E, et al. Prostaglandin E2 production by Mac2+ macrophages: Tumor-induced population shift. J Leuk Biol 1987; 42: 673–681
   PubMed Web of Science ®Google Scholar
• Parhar R S, Lala P K. Prostaglandin E2-mediated inactivation of various killer lineage cells by tumor-bearing host macrophages. J Leuk Biol 1988; 44: 474–484
   PubMed Web of Science ®Google Scholar
• Watson G A, Fu Y-X, Lopez D M. Splenic macrophages from tumor bearing mice coexpressing Mac-1 and Mac-2 antigens exert immunoregulatory functions via two distinct mechanisms. J Leuk Bio 1991; 49: 126–138
   PubMed Web of Science ®Google Scholar
• Dorizzi M, Ortiz-Muniz G, Lopez D M, et al. Increase in the proportion of cells with the C′3 receptor in Balb/c mice bearing mammary tumors, Int J. Cancer 1975; 16: 1015–1021
   Web of Science ®Google Scholar
• Fu Y-X, Paul R, Wang Y, Lopez D M. Thymic involution and thymocyte phenotypic alterations induced by murine mammary adenocarcinoma. J Immunol 1989; 143: 4300–4307
   PubMed Web of Science ®Google Scholar
• Fu Y-X, Airman N, Lopez D M. Thymic atrophy induced by a murine mammary adenocarcinoma in vivo. In Vivo 1989; 3: 1–6
   PubMedGoogle Scholar
• Granstein R D, Staszewski R, Knisley T L, et al. Aqueous tumor contains transforming growth factor-β and a small (> 3500 daltons) inhibitor of thymocyte proliferation. J Immunol 1990; 144: 3021–3027
   PubMed Web of Science ®Google Scholar
• Cornelius J G, Normann S J. Isolation of a low molecular weight inhibitor of lymphocyte proliferation from tumorous ascites. J Immunol 1988; 141: 2175–2180
   PubMed Web of Science ®Google Scholar
• Folkman J. How is blood vessel growth regulated in normal and neoplastic tissue?. Cancer Res 1986; 46: 467–473
   PubMed Web of Science ®Google Scholar
• Schor A M, Schor S L. Tumor angiogenesis. Pathology 1983; 141: 385–413
   Web of Science ®Google Scholar
• Kumar S, West D, Daniel M, et al. Human lung tumor cell line adapted to grow in serum-free medium secretes angiogenesis factor. Int J Cancer 1983; 32: 461–464
   PubMed Web of Science ®Google Scholar
• Polverini P J, Ldbovich S J. Induction of neovascularization in vivo and endothelial proliferation in vitro by tumor associated macrophages. Lab Invest 1984; 51: 635–642
   PubMed Web of Science ®Google Scholar
• Vallee B L, Riordan J F, Lobb R R, et al. Tumor derived angiogenesis factors from rat Walker 256 carcinoma: an experimental investigation and review. Experientia 1985; 41: 1–15
   PubMedGoogle Scholar
• Shing Y, Folkman J, Haudenschild C, et al. Angiogenesis is stimulated by a tumor-derived endothelial cell growth factor. J Cell Bioch 1985; 29: 275–2897
   PubMed Web of Science ®Google Scholar
• Frater-Schroder M, Risau W, Hallmann R, et al. Tumor necrosis factor type a, a potent inhibitor of endothelial cell growth in vitro is angiogenic in vivo. Proc Natl Acad Sci (USA) 1987; 84: 5277–5281
   PubMed Web of Science ®Google Scholar
• Folkman J, Klagsbrun M. Angiogenic factors. Science 1987; 235: 442–447
   PubMed Web of Science ®Google Scholar
• Ishiwata I, Ishiwata C, Soma M, et al. Tumor angiogenic activity of gynecologic tumor cell lines on the chorioallantoic membrane. Gynecol Oncol 1988; 29: 87–93
   PubMed Web of Science ®Google Scholar
• Folkman J, Watson K, Ingber D, et al. Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 1989; 339: 58–61
   PubMed Web of Science ®Google Scholar
• Abraham J A, Mergia A, Whang J L, et al. Nucleotide sequence of a bovine clone encoding during the angiogenic protein, basic fibroblast growth factor. Science 1986; 233: 545–548
   PubMed Web of Science ®Google Scholar
• Schreiber A B, Winkler M E, Derynck R. Transforming growth factor alpha: a more potent angiogenic mediator than epidermal growth factor. Science 1986; 232: 1250–1253
   PubMed Web of Science ®Google Scholar
• Leung D W, Cachianes G, Kuang W-J, et al. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989; 246: 1306–1309
   PubMed Web of Science ®Google Scholar
• Knighton D, Ausprunk D, Tapper D, et al. Avascular and vascular phases of tumor growth in the chick embryo. Br J Cancer 1977; 35: 347–368
   PubMed Web of Science ®Google Scholar
• Ruppert B, Blazer B, Medina D, et al. In situ lymphoid cells of mouse mammary tumors IV. Comparison of functional activity of lymphoid cells separated from mammary tumors to that of spleen and lymph node cells of tumor sensitized mice. J Immunol 1979; 122: 2180–2183
   PubMed Web of Science ®Google Scholar
• Haskill S. Intratumor effector cells: clinical and experimental studies. Tumor Immunity in Prognosis: the Role of Mononuclear Cell Infiltration, S Haskill. Marcel Dekker, New York 1982; 309–332
   Google Scholar
• Vaage J, Pepin K G. Morphological observations during developing concomitant immunity against a C3H/He mammary tumor. Cancer Res 1985; 45: 659–666
   PubMed Web of Science ®Google Scholar
• Rosenberg S A, Spiess P, Lafreniere R. A new approach to adoptive immunotherapy of cancer with tumor infiltrating lymphocytes. Science 1986; 233: 1318–1321
   PubMed Web of Science ®Google Scholar
• Rosenberg R A. Immunotherapy of cancer using interleukin 2: current status and future prospects. Immunol Today 1988; 9: 58–62
   PubMedGoogle Scholar
• Butcher E C. The regulation of lymphocyte traffic. Cur Top Microbiol Immunol 1986; 128: 85–122
   PubMed Web of Science ®Google Scholar
• Woodruff J J, Clarke L M, Chin Y H. Specific cell-adhesion mechanisms determining migration pathways of recirculating lymphocytes. Ann Rev Immunol 1987; 5: 201–222
   PubMed Web of Science ®Google Scholar
• Stoolman M L. Adhesion molecules controlling lymphocyte migration. Cell 1989; 56: 907–910
   PubMed Web of Science ®Google Scholar
• Chin Y H, Falanga V, Streilein J W, et al. Specific lymphocyte-endothelial cell interactions regulate migration into lymph nodes, Peyer's patches and skin. Regional Immunol 1988; 1: 78–83
   PubMedGoogle Scholar
• Sackstein R, Falanga V, Streilein J W, et al. Lymphocyte adhesion to psoriatic dermal endothelium is mediated by a tissue specific receptor/ligand interaction. J Invest Dermatol 1988; 91: 423–428
   PubMed Web of Science ®Google Scholar
• Jalkanen S, Steere A D, Fox R I, et al. A distinct endothelial cell recognition system that controls lymphocyte traffic into inflamed synovium. Science 1986; 233: 256–258
   Google Scholar
• Oppenheimer-Marks N, Ziff M. Binding of normal human mononuclear cells to blood vessels in rheumatoid arthritis synovial membrane. Arthritis Rheum 1986; 29: 789–792
   PubMed Web of Science ®Google Scholar
• Stamper H B, Woodruff J J. Lymphocyte homing into lymph nodes: in vitro demonstration of the selective affinity of recirculating lymphocytes for high endothelial venules. J Exp Med 1976; 144: 828–833
   PubMed Web of Science ®Google Scholar
• Lopez D M, Cideciyan D, Rao K, . Lymphocyte homing in mammary neoplasia. Lymphatic Tissues and In Vivo Immune Response, S Ezine, S Berrih-Aknin, B Imhof, et al. Marcel-Dekker, New York 1991; 947–951
   Google Scholar
• Fu Y-X, Watson G, Jimenez J J, et al. Expansion of immunoregulatory macrophages by granulocyte-macrophage colony-stimulating factor derived from a murine mammary tumor. Cancer Res 1990; 50: 227–234
   PubMed Web of Science ®Google Scholar
• Gough N M, Metcalf D, Gough J, et al. Structure and expression of the mRNA for murine granulocyte-macrophage colony stimulating factor. EMBO J 1985; 4: 645–653
   PubMed Web of Science ®Google Scholar
• Roberts A B, Sporn M B. Transforming growth factor-β. Adv Cancer Res, 51: 107–147
   PubMed Web of Science ®Google Scholar
• Deryneck R, Jarret J A, Chen E Y, et al. Human transforming growth factor-β complementary DNA sequence and expression in normal and transformed cells. Nature 1985; 316: 701–704
   PubMed Web of Science ®Google Scholar
• Sporn M B, Roberts A B. Autocrine growth factors and cancer. Nature 1985; 313: 745–747
   PubMed Web of Science ®Google Scholar
• Torre-Amione G, Beauchamp D R, Koeppen H, et al. A highly immunogenic tumor transfected with a murine transforming growth factor type β cDNA escapes immune surveillance. Proc Natl Acad Sci (USA) 1990; 87: 1486–1490
   PubMed Web of Science ®Google Scholar
• Aderka D, Le J, Vilcek J. Interleukin-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice. J Immunol 1989; 143: 3517–3523
   PubMed Web of Science ®Google Scholar
• Hart P H, Vitti G F, Burgess D R, et al. Potential antiinflammatory effects of interleukin 4: suppression of human monocyte tumor necrosis factor a, interleukin 1, and prostaglandin E2. Proc Natl Sci (USA) 1989; 86: 3803–3807
   PubMed Web of Science ®Google Scholar
• Tsuchiya Y, Igarashi R, Suzuki M, et al. Production of colony-stimulating factor by tumor cells and the factor-mediated induction of suppressor cells. J Immunol 1988; 141: 699–708
   PubMed Web of Science ®Google Scholar
• Metcalf D. Hemopoietic growth factors. Nature 1989; 339: 27–30
   PubMed Web of Science ®Google Scholar
• Rice G E, Bevilacqua M P. An inducible endothelial cell surface glycoprotein mediates melanoma adhesion. Science 1989; 246: 1303–1306
   PubMed Web of Science ®Google Scholar
• Wang J, Griffin M, Rambaldi J D, et al. Induction of monocyte migration by recombinant macrophage colony-stimulating factor. J Immunol 1988; 141: 575–579
   PubMed Web of Science ®Google Scholar
• Bamble J R, Elliot M J, Jaipargas E, et al. Regulation of human monocyte adherence by granulocyte-macrophage colony-stimulation factor. Proc Natl Acad Sci (USA) 1989; 86: 7159–7163
   PubMedGoogle Scholar
• Bussolino F, Wang J-M, Defilippi P, et al. Granulocyte- and granulocyte-macrophage-colony stimulating factors induce human endothelial cells to migrate and proliferate. Nature 1989; 337: 471–473
   PubMed Web of Science ®Google Scholar
• Leibovich S J, Porverini P J, Shepard H M, et al. Macrophage-induced angiogenesis is mediated by tumor necrosis factor-a. Nature 1987; 329: 630–632
   PubMed Web of Science ®Google Scholar
• Fuji T, Igarashi T, Kishimoto S. Significance of suppressor macrophages for immunosurveillance of tumor-bearing mice. J Natl Cancer Inst 1987; 78: 509–517
   PubMed Web of Science ®Google Scholar
• Mantovani A, Wang I M, Balotta C, et al. Origin and regulation of tumor-asociated macrophages. Biochem Biophys Acta 1986; 865: 59–67
   PubMed Web of Science ®Google Scholar
• Katz J D, Lebow T L, Bonavida B. The in vivo depletion of Vβ17a+ T cells results in the inhibition of reticulum cell sarcoma growth in SJL/J mice. J Immunol 1989; 143: 1387–1395
   PubMed Web of Science ®Google Scholar
• Botazzi B, Erba E, Nobill N, et al. A paracrine circuit in the regulation of the proliferation of macrophages infiltrating murine sarcomas. J Immunol 1990; 144: 2409–2412
   PubMed Web of Science ®Google Scholar
• Lang R A, Burgess A W. Autocrine growth factors and tumorigenic transformation. Immunol Today 1990; 11: 244–249
   PubMedGoogle Scholar
• Miles R A, Rezai A R, Salazar-Gonzalez J F, et al. AIDS Kaposi sarcoma-derived cells produce and respond to IL-6. Proc Natl Acad Sci (USA) 1990; 87: 4068–4072
   PubMed Web of Science ®Google Scholar
• Baldwin G C, Gasson J C, Kaufman S E, et al. Nonhematopoietic tumor cells express functional GM-CSF receptors. Blood 1989; 73: 1033–1037
   PubMed Web of Science ®Google Scholar
• Dedhar S, Gaboury S, Galloway P, et al. Human granulocyte-macrophage colony-stimulating factor is a growth factor active on a variety of cell types of nonhemopoietic organs. Proc Natl Acad Sci (USA) 1988; 85: 9253–9257
   PubMed Web of Science ®Google Scholar